Web1 dec. 2024 · In the German STOP-IGAN (Supportive Versus Immunosuppressive Therapy for the Treatment of Progressive IgA Nephropathy) trial, 162 participants with persistent proteinuria with protein excretion > 0.75 g/d and eGFRs ≥ 60 mL/min/1.73m 2 were assigned to supportive care with RAAS blockers or supportive care plus 3 methylprednisolone … Web24 dec. 2024 · IgA Nephropathy Medication: Angiotensin-converting enzyme inhibitors, Angiotensin II receptor antagonists, Corticosteroids, Omega-3 polyunsaturated fatty …
The Association of TNF-Alpha Inhibitors and Development of IgA ...
Web21 jul. 2024 · IgA nephropathy (nuh-FROP-uh-thee), also known as Berger's disease, is a kidney disease that occurs when an antibody called immunoglobulin A (IgA) builds up in … Web11 dec. 2024 · Die IgA-Nephritis ist weltweit gesehen die häufigste Form einer Glomerulonephritis. Ihr Anteil an allen Formen der primären Glomerulonephritis beträgt … cc とは 字幕
How I Treat IgA Nephropathy - kdigo.org
Web12 apr. 2024 · (April 12, 2024, New York, NY) — The National Kidney Foundation (NKF) will feature a late-breaking plenary session by Travere Therapeutics on the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating FILSPARI™ (sparsentan) in adults with IgA nephropathy (IgAN). Web5 mei 2024 · Background Chronic kidney disease has been linked to cardiovascular disease and specifically ischemic heart disease (IHD), but large-scale population data in patients with immunoglobulin A nephropathy (IgAN) are missing. Objective To examine absolute and relative risks for IHD in patients with IgAN. Methods Population-based register … Web6 apr. 2024 · Clinical features. 40 - 50%: at least one episode of visible hematuria associated to upper respiratory tract infection (synpharyngitic hematuria) ( UptoDate: Clinical Presentation and Diagnosis of IgA Nephropathy [Accessed 6 April 2024] ) 30 - 50%: microscopic hematuria. < 10%: nephrotic syndrome or rapidly progressive … ccとは 情報